Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-08-22 to 2025-12-21
Current total value of award: $4292641
Description: REVISED SOW INCORPORATED INTO CYTOSORBENTS DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "INTEGRATING ISOAGGLUTININ REDUCTION FOR A UNIVERSAL DRIED PLASMA PRODUCT FOR BATTLEFIELD AND FIRST RESPONDER USE"